Stakeholders letter - B listed Reminder 2021

Reference is made to the letter dated 10 February 2020 on the above subject matter.

The Botswana Medicines Regulatory Authority (BoMRA) commenced registration of B-listed products (products denoted with “B” in the Human Medicines Register / Blue book) therefore manufacturers are required to submit applications. To allow for a phased transition, variation applications for B-listed applications will only be allowed for changes that affect the following information in the Register / Blue Book:

Download Now

File name: Stakeholders letter-B-listed-Reminder-2021.pdf

4932 310